Keio University · Chemistry
Professor Tomoyuki Ohe's research lab specializes in drug metabolism and toxicology, with a focus on the metabolic activation of drugs and environmental chemicals by cytochrome P450 enzymes. The lab investigates novel metabolic pathways, such as the formation of quinols from para-alkylphenols and estrogens, and elucidates the mechanisms of reactive metabolite formation using isotopic labeling and trapping techniques. A key emphasis is on developing reliable methods to assess the bioactivation potential of new drug candidates, particularly through radiolabeled trapping reagents like [(35)S]cysteine and [(14)C]cyanide for early detection of reactive intermediates. The lab also explores structure–activity relationships of hepatotoxic drugs, such as diclofenac, to understand the roles of specific metabolites like quinone imines and acyl glucuronides in drug-induced liver injury.
Figures are computed from collected data and may differ slightly.
When various p-substituted phenols (substituent = NO2, CN, CH2OH, COCH3, COPh, COOH, F, Cl, and Br) were incubated with rat liver microsomes, the substituent was eliminated to produce hydroquinone, and the reaction was inhibited by CO and a cytochrome P450-specific inhibitor. In the case of p-cresol (substituent = CH3), p-toluquinol was formed instead of hydroquinone. Experiments using 18O2 proved that the elimination is accompanied with ipso-substitution by the oxygen atom of the active species
We have already reported that the quinol formation from some para-alkylphenols, which is a novel metabolic pathway catalyzed by cytochrome P-450, occurs in a rat liver microsomal system (). In the present study, we investigated whether estrone and 17beta-estadiol, each of which contains a p-alkylphenol moiety, are also oxidized into the corresponding quinols by cytochrome P-450. Six recombinant human cytochrome P-450 enzymes, CYP1A1, CYP1A2, CYP2B6, CYP2C9, CYP2E1, and CYP3A4, were tested. The r
A trapping approach for semi-quantitative assessment of bioactivation potential has been established for new chemical entities by using [(35)S]cysteine and [(14)C]sodium cyanide as trapping reagents. Reactive metabolites were trapped as radioactive adducts with the trapping reagents to be analyzed by radio-LC(/MS). As a reference, hepatotoxic drugs (clozapine, diclofenac, R-(+)-pulegone and troglitazone) were tested in the [(35)S]cysteine trapping assay and the proposed structures of the cystein
Diclofenac (DCF) is widely used as a nonsteroidal anti-inflammatory drug; however, it is associated with severe liver injury. This adverse reaction is thought to be related to the reactive quinone imine (QI) and acyl glucuronide (AG) metabolites of DCF, but it remains controversial which reactive metabolites mainly contribute to DCF-induced toxicity. In this study, we synthesized five types of DCF analogs that were designed to mitigate the formation of reactive QI and/or AG metabolites and evalu
Open papers in the app to read, cite, and organize with AI.
